SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 424B5 - Prospectus [Rule 424(b)(5)]:
SEC Accession No. 0001062993-20-004398
Filing Date
2020-09-09
Accepted
2020-09-08 18:48:07
Documents
3

Document Format Files

Seq Description Document Type Size
1 FORM 424B5 form424b5.htm 424B5 209377
2 GRAPHIC form424b5x001.jpg GRAPHIC 12639
3 GRAPHIC form424b5x002.jpg GRAPHIC 6083
  Complete submission text file 0001062993-20-004398.txt   236409
Mailing Address 2488 DUNWIN DRIVE MISSISSAUGA A6 L5L 1J9
Business Address 2488 DUNWIN DRIVE MISSISSAUGA A6 L5L 1J9 (416) 595-0627
Trillium Therapeutics Inc. (Filer) CIK: 0001616212 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A6 | Fiscal Year End: 1231
Type: 424B5 | Act: 33 | File No.: 333-237810 | Film No.: 201165107
SIC: 2834 Pharmaceutical Preparations